Researcher profile

A. Bel

A. Bel contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 11 - UnverifiedVerification L1Unclaimed author
1works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2021arXiv

Surrogate-free machine learning-based organ dose reconstruction for pediatric abdominal radiotherapy

To study radiotherapy-related adverse effects, detailed dose information (3D distribution) is needed for accurate dose-effect modeling. For childhood cancer survivors who underwent radiotherapy in the pre-CT era, only 2D radiographs were acquired, thus 3D dose distributions must be reconstructed from limited information. State-of-the-art methods achieve this by using 3D surrogate anatomies. These can lack personalization and lead to coarse reconstructions. We present and validate a surrogate-free dose reconstruction method based on Machine Learning (ML). Abdominal planning CTs ($n$=142) of recently-treated childhood cancer patients were gathered, their organs at risk were segmented, and 300 artificial Wilms' tumor plans were sampled automatically. Each artificial plan was automatically emulated on the 142 CTs, resulting in 42,600 3D dose distributions from which dose-volume metrics were derived. Anatomical features were extracted from digitally reconstructed radiographs simulated from the CTs to resemble historical radiographs. Further, patient and radiotherapy plan features typically available from historical treatment records were collected. An evolutionary ML algorithm was then used to link features to dose-volume metrics. Besides 5-fold cross-validation, a further evaluation was done on an independent dataset of five CTs each associated with two clinical plans. Cross-validation resulted in Mean Absolute Errors (MAEs) $\leq$0.6 Gy for organs completely inside or outside the field. For organs positioned at the edge of the field, MAEs $\leq$1.7 Gy for D$_{mean}$, $\leq$2.9 Gy for D$_{2cc}$, and $\leq$13% for V$_{5Gy}$ and V$_{10Gy}$, were obtained, without systematic bias. Similar results were found for the independent dataset. Our novel, ML-based organ dose reconstruction method is not only accurate but also efficient, as the setup of a surrogate is no longer needed.